Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia.
Am J Kidney Dis. 2010 Apr;55(4):690-7. doi: 10.1053/j.ajkd.2009.11.015. Epub 2010 Jan 29.
Reports of culture-negative peritoneal dialysis (PD)-associated peritonitis have been sparse, conflicting, and limited to small single-center studies. The aim of this investigation is to examine the frequency, predictors, treatment, and outcomes of culture-negative PD-associated peritonitis.
Observational cohort study using Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) data.
SETTING & PARTICIPANTS: All Australian PD patients between October 1, 2003, and December 31, 2006.
Demographic, clinical, and facility variables.
OUTCOMES & MEASUREMENTS: Culture-negative PD-associated peritonitis occurrence, relapse, hospitalization, catheter removal, hemodialysis transfer, and death.
Of 4,675 patients who received PD in Australia during the study period, 435 episodes of culture-negative peritonitis occurred in 361 individuals. Culture-negative peritonitis was not associated with demographic or clinical variables. A history of previous antibiotic treatment for peritonitis was more common with culture-negative than culture-positive peritonitis (42% vs 35%; P = 0.01). Compared with culture-positive peritonitis, culture-negative peritonitis was significantly more likely to be cured using antibiotics alone (77% vs 66%; P < 0.001) and less likely to be complicated by hospitalization (60% vs 71%; P < 0.001), catheter removal (12% vs 23%; P < 0.001), permanent hemodialysis therapy transfer (10% vs 19%; P < 0.001), or death (1% vs 2.5%; P = 0.04). Relapse rates were similar between the 2 groups. Patients with relapsed culture-negative peritonitis were more likely to have their catheters removed (29% vs 10% [P < 0.001]; OR, 3.83; 95% CI, 2.00-7.32). Administration of vancomycin or cephalosporin in the initial empiric antibiotic regimen and the timing of catheter removal were not significantly associated with clinical outcomes.
Limited covariate adjustment. Residual confounding and coding bias could not be excluded.
Culture-negative peritonitis is a common complication with a relatively benign outcome. A history of previous antibiotic treatment is a significant risk factor for this condition.
关于无培养阳性结果的腹膜透析(PD)相关性腹膜炎的报告很少,且相互矛盾,仅限于小的单中心研究。本研究旨在调查无培养阳性 PD 相关性腹膜炎的频率、预测因素、治疗和结局。
使用澳大利亚和新西兰透析和移植登记处(ANZDATA)数据的观察性队列研究。
2003 年 10 月 1 日至 2006 年 12 月 31 日期间,所有在澳大利亚接受 PD 的患者。
人口统计学、临床和机构变量。
无培养阳性 PD 相关性腹膜炎的发生、复发、住院、导管移除、血液透析转移和死亡。
在研究期间,在澳大利亚接受 PD 的 4675 名患者中,有 361 名患者发生了 435 例无培养阳性腹膜炎。无培养阳性腹膜炎与人口统计学或临床变量无关。与培养阳性腹膜炎相比,无培养阳性腹膜炎的患者既往抗生素治疗腹膜炎的病史更为常见(42% vs. 35%;P = 0.01)。与培养阳性腹膜炎相比,无培养阳性腹膜炎更有可能仅使用抗生素治愈(77% vs. 66%;P < 0.001),并且不太可能因住院(60% vs. 71%;P < 0.001)、导管移除(12% vs. 23%;P < 0.001)、永久性血液透析治疗转移(10% vs. 19%;P < 0.001)或死亡(1% vs. 2.5%;P = 0.04)而变得复杂。两组的复发率相似。复发无培养阳性腹膜炎的患者更有可能移除导管(29% vs. 10%[P < 0.001];比值比,3.83;95%置信区间,2.00-7.32)。初始经验性抗生素治疗方案中万古霉素或头孢菌素的应用以及导管移除的时间与临床结局无显著相关性。
有限的协变量调整。残余混杂和编码偏倚不能排除。
无培养阳性腹膜炎是一种常见的并发症,具有相对良性的结局。既往抗生素治疗史是这种情况的一个显著危险因素。